Purchases and Sales Made in Q4 2025 in Akebia Therapeutics, Inc. (AKBA)
This table provides information about the institutional ownership of Akebia Therapeutics, Inc. (AKBA) during Q4 2025. The information is specifically focused on institutions that hold shares of Akebia Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Jan 08, 2026
Q4 2025
|
Nordea Investment Management Ab
Stockholm, V7 |
BUY
|
- |
752KNew |
$1.26M - $2.38M
|
752K
$1.28M
|
|
|
Jan 14, 2026
Q4 2025
|
Hennion & Walsh Asset Management, Inc.
|
BUY
|
- |
499KNew |
$833K - $1.58M
|
499K
$848K
|
|
|
Jan 09, 2026
Q4 2025
|
Sg Americas Securities, LLC
|
BUY
|
- |
57.1K+ 49.06% |
$95.4K - $181K
|
174K
$295K
|
|
|
Jan 12, 2026
Q4 2025
|
Traynor Capital Management, Inc.
|
BUY
|
- |
14.6KNew |
$24.4K - $46.3K
|
14.6K
$24.8K
|
|
|
Jan 08, 2026
Q4 2025
|
Carr Financial Group Corp
Worcester, MA |
BUY
|
- |
11.6KNew |
$19.3K - $36.7K
|
11.6K
$19.7K
|
|
|
Jan 15, 2026
Q4 2025
|
Nisa Investment Advisors, LLC
|
SELL
|
- |
-66- 2.18% |
$110 - $209
|
2.96K
$5.02K
|
|
|
Jan 09, 2026
Q4 2025
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-402K- 94.17% |
$671K - $1.27M
|
24.9K
$42.3K
|
|